DL-BUTHIONINE-[S,R]-SULFOXIMINE
Synonym(s):DL -Buthionine (S,R)-sulfoximine;BSO;Buthionine sulfoximine;Butionine sulfoximine
- CAS NO.:5072-26-4
- Empirical Formula: C8H18N2O3S
- Molecular Weight: 222.31
- MDL number: MFCD00070309
- EINECS: 628-045-7
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-11-20 11:41:24
What is DL-BUTHIONINE-[S,R]-SULFOXIMINE?
Chemical properties
White Crystalline Solid
The Uses of DL-BUTHIONINE-[S,R]-SULFOXIMINE
A potent and specific inhibitor of alpha-glutamyl cysteine synthetase
The Uses of DL-BUTHIONINE-[S,R]-SULFOXIMINE
Biological tool for depletion of glutathione.
The Uses of DL-BUTHIONINE-[S,R]-SULFOXIMINE
DL-Buthionine-sulfoximine is suitable for use to:
- examine whether the inhibition of glutathione by BSO enhances the apoptotic effect of estrogen on antihormone-resistant human breast cancer cells
- investigate the effect of BSO on development of bovine embryos
- inhibit GSH in several studies
- investigate the effect of GSH synthesis on oocyte maturation
What are the applications of Application
D,L-Buthionine-(S,R)-sulfoximine is a gamma-GCSc inhibitor which decreases the proliferative response of T-lymphocytes
Definition
ChEBI: A sulfoximide that is the sulfoximine derivative of an analogue of DL-methionine in which the S-methyl group is replaced by S-butyl.
General Description
DL-buthionine-SR-sulfoximine (BSO) is an amino acid analogue, which acts as an inhibitor of γ-glutamylcysteine synthetase. BSO increases the sensitivity of Trypanosoma cruzi to antiparasitic drugs, such as nifurtimox or benznidazole.
Biochem/physiol Actions
DL-Buthionine-sulfoximine inhibits the biosynthesis of Glutathione (GSH) in liver and other peripheral organs. It does not have any effect on GSH in the CNS. It augments the antiproliferative action of reactive oxygen species (e.g., hydrogen peroxide), and agents that indirectly cause accumulation of reactive oxygen species (e.g., 2-methoxyestradiol, which increases intracellular superoxide anion).
Properties of DL-BUTHIONINE-[S,R]-SULFOXIMINE
Melting point: | 215 °C (dec.)(lit.) |
Boiling point: | 382.3±52.0 °C(Predicted) |
Density | 1.29±0.1 g/cm3(Predicted) |
storage temp. | 2-8°C |
solubility | H2O: 50 mg/mL, clear, colorless |
form | Fluffy Powder |
color | White |
Merck | 13,1520 |
BRN | 2367136 |
CAS DataBase Reference | 5072-26-4(CAS DataBase Reference) |
Safety information for DL-BUTHIONINE-[S,R]-SULFOXIMINE
Signal word | Warning |
Pictogram(s) |
Exclamation Mark Irritant GHS07 |
GHS Hazard Statements |
H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P271:Use only outdoors or in a well-ventilated area. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for DL-BUTHIONINE-[S,R]-SULFOXIMINE
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Mefenamic Acid IP/BP/EP/USP Diclofenac Sodium IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
DL-Buthionine-(S,R)-sulfoximine 99.00% CAS 5072-26-4View Details
5072-26-4 -
DL-Buthionine-sulfoximine CAS 5072-26-4View Details
5072-26-4 -
DL-Buthionine-(S,R)-sulfoximine CAS 5072-26-4View Details
5072-26-4 -
1823368-42-8 98%View Details
1823368-42-8 -
2-(3-(tert-butyl)phenoxy)-2-methylpropanoic acid 1307449-08-6 98%View Details
1307449-08-6 -
Ethyl 3-(furan-2-yl)-3-hydroxypropanoate 25408-95-1 98%View Details
25408-95-1 -
2-Chloro-5-fluoro-1-methoxy-3-methylbenzene 98%View Details
1805639-70-6 -
Lithium ClavulanateView Details
61177-44-4